ATRIN PHARMACEUTICALS

General Information
Company Name
ATRIN PHARMACEUTICALS
Founded Year
2011
Location (Offices)
Ambler, United States +1
Founders / Decision Makers
Number of Employees
4
Industries
Biotechnology, Pharmaceutical
Funding Stage
Series A
Social Media

ATRIN PHARMACEUTICALS - Company Profile

ATRIN PHARMACEUTICALS is a pharmaceuticals company based out of 1040 GLENDEVON DR, AMBLER, Pennsylvania, United States. Founded in 2011, the company operates within the Biotechnology and Pharmaceutical industries. ATRIN PHARMACEUTICALS recently received their Series A investment on 02 July 2022, with Keiretsu Capital as the investors. This signals a noteworthy milestone for the company, indicating its potential for growth and innovation in the pharmaceutical sector. With its strategic location and focused investment, ATRIN PHARMACEUTICALS is poised to make significant strides in the medical field.

Taxonomy: pharmaceuticals, development, medical, drug discovery, innovation, Pennsylvania, US-based company

Funding Rounds & Investors of ATRIN PHARMACEUTICALS (6)

View All
Funding Stage Amount No. Investors Investors Date
Series A Unknown 1 02 Jul 2022
Venture Round Unknown 1 11 May 2022
Convertible Note $150.00K 2 Keiretsu Forum 01 Feb 2019
Grant $300.00K 1 National Cancer Institute 19 Oct 2016
Venture Round $1.23M - 01 Apr 2016

View All 6 Funding Rounds

Latest News of ATRIN PHARMACEUTICALS

View All

No recent news or press coverage available for ATRIN PHARMACEUTICALS.